Raven PB. The effects of aerobic fitness and ␤1-adrenergic receptor blockade on cardiac work during dynamic exercise. J Appl Physiol 106: 486 -493, 2009. First published November 26, 2008 doi:10.1152/japplphysiol.90795.2008.-The purpose of this investigation was to determine whether cardiovascular adaptations characteristic of long-term endurance exercise compensate more effectively during cardioselective ␤1-adrenergic receptor blockade-induced reductions in sympathoadrenergic-stimulated contractility. Endurancetrained (ET) athletes (n ϭ 8) and average-trained (AT; n ϭ 8) subjects performed submaximal cycling exercise at moderate [45% maximum oxygen uptake (V O2max)] and heavy (70% V O2max) workloads, with and without metoprolol. Cardiac output (Q c), heart rate (HR), and systolic blood pressure were recorded at rest and during exercise. Cardiac work was calculated from the triple product of HR, stroke volume, and systolic blood pressure, and myocardial efficiency is represented as cardiac work for a given total body oxygen consumption. Metoprolol reduced Q c at 45% V O2max (P ϭ 0.004) and 70% V O2max (P ϭ 0.022) in ET subjects, but did not alter Q c in the AT subjects. In ET subjects at 45% V O2max, metoprolol-induced reductions in Q c were a result of decreases in HR (P Ͻ 0.05) and the absence of a compensatory increase in stroke volume (P Ͼ 0.05). The cardiac work and calculated cardiac efficiency were reduced with metoprolol in ET subjects at both exercise intensities and in the AT subjects during the high-intensity workload (P Ͻ 0.01). The cardiac work and the calculated cardiac efficiency were not affected by metoprolol in the AT subjects during the 45% V O2max exercise. Therefore, in AT subjects, ␤-blockade reduced the amount of pressure generation necessary to produce the same amount of work during moderate-intensity exercise. In patients with heart disease receiving metoprolol, a decrease in the generation of cardiac pressure necessary to perform a given amount of work during mild-to-moderate exercise would prove to be beneficial.
ISCHEMIC HEART DISEASE PATIENTS are routinely prescribed cardio-selective ␤ 1 -adrenergic receptor (BAR) blockers, with the aim of reducing the exercise-induced increases in heart rate (HR) below the ischemic threshold for cardiac arrhythmias. In short, by reducing the HR for a given intensity of exercise, it is presumed the cardiac work required to perform the physical work would be reduced. However, it is well established that the relationship between cardiac output (Q c) and oxygen uptake (V O 2 ) is linear and invariant (8) . Therefore, one would predict that a reduction in HR at any given work intensity would increase cardiac filling time and, consequently, by reason of the Frank-Starling mechanism (7, 26) , increase stroke volume (SV) and maintain cardiac work. Indeed, Joyner et al. (20) , in a comparison of ␤ 1 -(Atenolol) and ␤ 1 -and ␤ 2 -adrenergic receptor (Propranolol) blockers, reported similar increases in SV in endurance exercise-trained (ET) and untrained (UT) men during 60% maximum V O 2 (V O 2max ) treadmill exercise with BAR blockade. These results suggest that, despite adaptively large cardiac preloads during exercise, ET athletes are further able to increase SV during exercise with pharmacologically induced increases in cardiac filling time.
It has been well established that, in the ET athlete compared with UT subjects, there are significant increases in eccentric cardiac hypertrophy, cardiac compliance (17, 26, 47) , and circulating blood volume (6, 31) . The observed ventricular remodeling associated with endurance exercise training (9, 11, 12, 33, 35) enables the ET athlete to continue to increase his SV during progressive increases in exercise workloads (14) . Conversely, the UT subject's exercise SV plateaus at ϳ40% V O 2max (2, 14) . The observed plateau in SV in UT individuals was thought to be a result of pericardial restraint (18, 42) . However, the presence of a 27% increase in SV in the UT subjects performing treadmill exercise at 60% V O 2max with BAR blockade (20) suggests that, with increased cardiac filling time, the Frank-Starling mechanism remains functional, and that pericardial restraint is not a factor in the initial portion of the SV plateau. In fact, a further increase in SV during exercise with BAR blockade may allow cardiac work to be maintained, despite the characteristic attenuation of the increase in HR and systolic blood pressure (SBP). Furthermore, ET individuals have been reported to function on a steeper portion of the Frank-Starling mechanism (26) . Therefore, the more efficient extrusion of blood is a product of greater volume loading, in contrast to an increased generation of pressure. This enables the ET heart to be capable of a more efficient use of energy to extrude the same volume of blood.
Therefore, the purpose of this study was to evaluate the effects of cardio-selective ␤-adrenergic blockade on the ability to maintain cardiac work in average-fit and high-fit subjects during moderate-(45% V O 2max ) and heavy-intensity (70% V O 2max ) cycling exercise. We hypothesized that, due to greater cardiac compliance, larger circulating blood volumes (2, 10, 26, 47) , and the absence of a functional pericardial restraint during moderate-to-heavy exercise intensity (14) , the ET athlete's heart would compensate for the BAR blockade-induced reduction in myocardial contractility more effectively than average-trained (AT) individuals. We tested these hypotheses by comparing the cardiac work (HR ϫ SV ϫ SBP) of AT and ET subjects at 45 and 70% V O 2max steady-state cycling exercise, with and without cardio-selective ␤ 1 -adrenergic (Metoprolol) blockade.
METHODS

Subjects.
Sixteen men were recruited as volunteer subjects from the Dallas-Fort Worth metroplex area bicycle riding, triathalon, athletic, and health fitness clubs. Only men were selected as subjects, because women do not develop substantial increases in absolute left ventricular (LV) wall thickness in response to endurance training and have significantly smaller changes in LV cavity dimensions (34) . The subjects were aged between 18 and 35 yr and were free of over-thecounter and prescription medications. Each subject was informed of the study protocol, gave written, informed consent, completed a health history questionnaire, and underwent seated and standing 12-lead electrocardiography without evidence of ischemia or arrhythmia. Of the 16 volunteer subjects, 8 were endurance ET competitive longdistance bicyclists and runners (V O2max ϭ 62.4 ϩ 4.5 ml⅐kg Ϫ1 ⅐min
Ϫ1
). The other eight subjects were involved in a consistent, yet moderate, aerobic fitness program and deemed AT (V O2max ϭ 44.5 ϩ 4.8 ml ⅐ kg Ϫ1 ⅐ min Ϫ1 ). Demographic and descriptive cardiac structural measures of both groups are presented in Table 1 . All experimental procedures conformed to the ethical considerations as approved by the Institutional Review Board for Human Subjects of the University of North Texas Health Science Center at Fort Worth and conformed to the principles in the Declaration of Helsinki.
Experimental protocols. Before performing their individual exercise stress test, the subjects were examined with resting electrocardiogram (ECG) and echocardiography (Echo) in the supine position. Following their cardiac evaluation, the subjects performed a graded exercise stress test on a stationary electrically braked cycle ergometer (Scifit) to volitional exhaustion to determine V O2max. The initial workload of the exercise stress test was 50 W, and each minute the workload was progressively increased, dependent on the individual subject's predicted aerobic fitness, to ensure that volitional exhaustion was reached within 6 -10 min (3). The AT subjects pedaled at 60 rpm, and the ET subjects were allowed to pedal at the frequency at or above 60 rpm that they used during competition.
On a separate experimental day, at least 2 days after their individual maximal exercise stress test, each subject performed four steady-state 25-min cycle exercise trials on the electronically braked cycle ergometer at the same pedal frequency at which they performed their maximal exercise stress test. The first two submaximal exercise bouts were control trials performed at 45% V O2max (moderate) and 70% V O2max (heavy) exercise intensities, respectively. After reaching their required steady-state V O2, measurements of HR, Q c, and SBP and diastolic arterial blood pressure (DBP) were obtained at 5-min intervals.
After completion of the control exercise trials, the subjects were allowed to recover for 2 h. At the beginning of the 2-h recovery period, the subjects ingested 50 mg of short-acting metoprolol to enable maximal efficacy and blockade of the BARs on the heart (46). Pharmacokinetic profiles of ingested metoprolol identify that a peak plasma value occurs 2 h after ingestion and is maintained constant for approximately another 2-4 h (46) .
Following the 2-h recovery period, a second pair of submaximal (45 and 70% V O2max) exercise trials was performed at the individual's same pedal frequency employed during the first two trials before the 2-h recovery period. Measurements of Q c, HR, SBP, and DBP were repeated at 5-min intervals. A schematic outline of the experimental protocol is presented in Fig. 1 .
Measurements. Supine, resting echocardiographic measurements of LV mass (LVM) were obtained using Doppler ultrasound echocardiography (Phillips HDI 5000) interfaced with a videographic recorder (Sony SVO-1410). The same echocardiographer made recordings and measurements for each of the subjects. A 2-to 4-MHz probe transducer was placed between the second and fourth intercostal space lateral to the sternum. Measurements were recorded in parasternal long-axis and short-axis views. LV dimensions measured by M-mode echocardiography included end-diastolic internal diameter, end-diastolic posterior wall thickness, and end-diastolic interventricular septal thickness. The LVM (g) was determined using the Penn convention (23): LVM ϭ 1.04 ϫ (end-diastolic diameter ϩ posterior wall).
Subjects were instrumented with a standard three-lead ECG (model 78342A, Hewlett Packard) for continuous monitoring of HR during cycling exercise. V O2 was continuously monitored by respiring through a mouthpiece attached to a low-resistance turbine volume transducer (Sensor Medics, VMM series) for measurement of breath volumes. Respiratory gases were continuously sampled from the mouthpiece for fractional concentrations of oxygen, carbon dioxide, and nitrogen via mass spectrometery (Perkin-Elmer MGA-1100A). Device input signals underwent analog-to-digital conversion and computer analysis (Dell Optiplex GXi) for online, breath-by-breath determinations. A customized software package was employed to correct for equipment delay and response times. Standardized calculations of metabolic data were corrected for ambient conditions, and measurements were averaged for each workload.
In addition, Q c was measured every 5 min via an acetylene rebreathe technique, as described previously (44), with SV being calculated from the division of Q c by HR. Unpublished data from our laboratory verified the reproducibility of the acetylene rebreathe technique. Ten subjects performed cycling exercise at two separate exercise intensities (40% and 60% V O2max) on two separate visits to the laboratory. The order in which the exercise intensity was performed was randomized for each visit with a 2-h break between each session to allow hemodynamic variables to return to baseline. The Q c was measured every 5 min at rest and during exercise. We found the technique to produce highly reproducible Q c values (r 2 ϭ 0.88) for the two visits. In addition, the average coefficient of variation for the low-and high-intensity workload was 7.2 and 8.4%, respectively.
Absolute SBP and DBP were recorded simultaneously with each rebreathe via an automated ambulatory arm cuff, which detects the Korotokoff sounds via microphone (Suntech Tango). During treadmill exercise-ECG testing, the combined mean difference between invasive and automated SBP and DBP was 4.79 Ϯ 0.14 and 6.33 Ϯ 0.10 mmHg, respectively (5) .
The triple product of SBP, HR, and SV was used as an index of cardiac work (37) . Cardiac efficiency was calculated as cardiac work for a given average total body V O2 obtained during the respective exercise trial. The traditional denominator of myocardial V O2 (mV O2) was substituted with total body V O2 to ascertain mV O2, despite our inability to directly measure mV O2 in a laboratory setting in humans during exercise. The indirect measurement of mV O2 is remarkably similar to our indirect measure of cardiac work, which results in a cancellation of most of the calculated products. Therefore, we chose a whole body measurement of V O2 with the understanding that a portion of that measurement supplies the heart and responds the same to exercise.
Statistical analysis. Demographic data are presented as means Ϯ SD. Experimental data are presented as means Ϯ SE. Power analysis was performed with cardiac work data from four ET and four AT subjects, with and without metoprolol, to determine the number of subjects required to confidently identify significant differences. Paired (within groups) and unpaired (between groups) t-tests were used to determine significance differences for two variables. ANOVA was performed when comparing multiple factors. Overall significance was further tested via post hoc analyses using Student-Newman-Keuls test for intergroup comparison. Differences between means were determined to be significant, if P Ͻ 0.05. Analyses were conducted using SigmaStat (Jandel Scientific Software, SPSS) software.
RESULTS
Evidence of endurance training in ET subjects. The subject's demographic characteristics and LV dimensions are presented in Table 1 . The values obtained for LVM and LV dimensions were comparable with those observed in ECG studies using similar techniques on similar groups of individuals of average fitness and endurance-trained competitive athletes (27, 33) . The ET athletes' V O 2max , LVM, LV wall thickness, and LV internal diameter were greater than those of AT subjects (P Ͻ 0.01). In addition, body weights and resting HRs of the ET subjects were less than those of the AT subjects (P ϭ 0.04, P ϭ 0.03, respectively).
BAR blockade induced changes in cardiovascular function during exercise. During control conditions, HR, SBP, Q c, and SV increased significantly from rest to 45% V O 2max exercise and to 70% V O 2max exercise in both groups of subjects. The DBP did not change in the AT subjects during exercise or with increases in the intensity of exercise; however, the DBP of the ET subjects was reduced at both exercise workloads compared with rest and was decreased further with the increase in exercise intensity (P Ͻ 0.05). Metoprolol had no significant effect on DBP in AT or ET subjects during exercise at either intensity; however, DBP was reduced during rest with metoprolol in ET subjects (Table 2) .
At rest, metoprolol had no significant effect on HR in AT subjects. However, the resting HR of the ET subjects was reduced (P Ͻ 0.05, Fig. 2A ). In addition, the HRs with metoprolol were reduced during exercise in both the AT and ET compared with the control (no metoprolol) exercise condition at both exercise intensities (P Ͻ 0.05, Fig. 2A) . The SBP was also decreased in the AT and ET subjects during exercise at both workloads (P Ͻ 0.01), but was not significantly different at rest in either group (Fig. 2B) . Metoprolol did not change the Q c at rest or during exercise in AT (P Ͼ 0.05, Fig.  2C ). However, the Q c at moderate-(P ϭ 0.004) and heavyintensity (P ϭ 0.022) exercise was reduced post-BAR blockade in the ET subjects compared with control (no metoprolol) exercise (Fig. 2C ). In the AT subjects, SV was significantly larger after BAR blockade at rest and during both exercise workloads compared with control (no metoprolol) conditions (P Ͻ 0.01, Fig. 2D ). In ET subjects, metoprolol-induced reductions in Q c were a result of the decreases in HR (P Ͻ 0.05) and a reduced compensatory increase in SV (P Ͼ 0.05). However, heavy-intensity exercise with metoprolol did elicit an increase in SV compared with control exercise in the ET subjects (P ϭ 0.026, Fig. 2D ). BAR blockade did not significantly alter V O 2 or DBP at rest or during exercise conditions compared with control.
BAR blockade effects on myocardial work at rest and during dynamic exercise. The effects of BAR blockade on cardiac work performed at rest and during moderate and intense cycling exercise workloads are summarized in Fig. 3 . Cardiac work was calculated from the triple product of HR, SBP, and SV. During each condition, the calculated cardiac work was greater in the ET subjects compared with the AT subjects (P Ͻ 0.05). At rest, metoprolol did not significantly affect the cardiac work of either the AT or ET subjects. However, during moderate-intensity exercise, metoprolol did not augment cardiac work of the AT subjects compared with control (no metoprolol) exercise at the same intensity. Conversely, metoprolol reduced the cardiac work (P Ͻ 0.01) of the ET subjects performing 45% V O 2max intensity exercise. In both groups of subjects performing heavy-intensity exercise, BAR blockade decreased calculated cardiac work (P Ͻ 0.01).
BAR blockade effects of myocardial efficiency at rest and during dynamic exercise. Cardiac efficiency is represented as cardiac work, calculated from the triple product, for a given total body V O 2 . The effect of metoprolol on cardiac efficiency at rest and during exercise in the AT and ET subjects is presented in Fig. 4 . At rest and during the 45% V O 2max exercise control (no metoprolol) condition, the calculated cardiac efficiencies of the ET subjects were increased above those of the AT subjects (P ϭ 0.05 and P Ͻ 0.04, respectively). Metoprolol did not alter the calculated cardiac efficiency within either group of subjects at rest (P Ͼ 0.05). In addition, the calculated cardiac efficiency of the AT subjects was not affected by metoprolol during the 45% V O 2max exercise. However, BAR blockade reduced the calculated cardiac efficiency of the ET subjects performing moderate-and heavy-intensity exercise (P Ͻ 0.01). Fig. 1 . Schematic diagram of experimental protocol for control and experimental exercise trials. The cardiac output (Q c), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were measured every 5 min during rest and each exercise bout. Heart rate (HR) was monitored continuously. V O2max, maximum oxygen uptake.
DISCUSSION
The main finding of this investigation was the presence of an impairment of cardiac function and a reduction in the cardiac work and calculated cardiac efficiency of ET subjects performing 45% and 70% V O 2max exercise after cardio-selective BAR blockade with metoprolol. In contrast, these same effects were not observed in the AT subjects with moderate-intensity exercise. This difference appears to be related to the AT subject's ability to increase SV and maintain Q c, cardiac work, and cardiac efficiency during moderate-intensity exercise, despite inhibition of sympathoadrenal stimulating influences on myocardial contractility (43) . However, the decrease in HR and SBP and maintenance of DBP and V O 2 during exercise with BAR blockade compared with control exercise in both groups of subjects confirm the findings of previous studies (1, 4, 20, 28, 40, 45) . The effect of BAR blockade on augmenting Q c during exercise has remained a controversial issue, with some studies reporting a decrease in Q c during exercise after BAR blockade compared with control exercise (20, 22, 32) , while others have reported no significant difference (4, 45) . Many of these discrepancies are most likely a result of the pharmacological agent used to induce the cardio-selective BAR blockade, the intensity of exercise performed, the subject's V O 2max , and the age of the subjects.
Initially, we hypothesized that the ET subjects would be more capable than AT in maintaining cardiac work during exercise, despite the BAR blockade-induced reduction in myocardial contractility. It has been previously demonstrated that, during dynamic exercise, the SV of sedentary individuals' plateaus at ϳ40 -45% V O 2max exercise (2, 14) . At higher exercise intensities, increases in HR and contractility become the predominate mechanisms employed to further increase Q c (36) . In contrast, the adaptations elicited by endurance exercise training, such as increased myocardial compliance (26, 47) , circulating blood volume (6, 31) , and the absence of pericardial restraint (18, 42) , allow the athlete to respond to exercise more effectively. Levine et al. (26) demonstrated that endurance ET athletes have a greater ability to utilize the Frank-Starling law of the heart to increase Q c in the face of various ventricular volume loads at rest. Starling's law of the heart is independent of calcium-induced changes in contractility via adrenergic stimulation of the BARs and allows for a stretch-induced increase in force of contraction resultant of increased filling volume (15, 19) . Levine et al. (26) demonstrated that athletes operate on a steeper portion of the Frank-Starling curve. Therefore, for a given change in filling pressure, due to volume loading, ET athletes had a greater capacity to increase SV (26) . In addition, other investigations have demonstrated that the athletes' enhanced ventricular filling is a result of greater use of the Frank-Starling mechanism (7). This mechanism is more energy efficient, due to a greater reliance on ventricular volume loads as opposed to generating an increase in pressure, and allows for further increases in SV at high exercise intensities. Values are means Ϯ SE. ⌬, Change. HR, heart rate; SBP, systolic blood pressure; DBP diastolic blood pressure; V O2, oxygen uptake; Q c, cardiac output; SV stroke volume; mV O2, myocardial V O2 (cardiac work). *Significantly different from control condition, P Ͻ 0.05. †Significantly different from average trained, P Ͻ 0.05.
However, during BAR blockade-induced reductions in contractility, the present study has demonstrated that ET subjects were not able to maintain Q c, despite increases in filling time and increased stretch of the ventricle. These results were largely due to the inability to increase SV beyond that obtained during control exercise. As mentioned above, the cardiac performance of ET subjects is on the plateau end of the ventricular function curve (26) . Therefore, removing the ability to increase contractility and transition to another ventricular function curve with BAR blockade may limit the ET subjects' capability of increasing SV during moderate-intensity exercise with metoprolol. Conversely, Q c of the AT subjects was no different at either exercise workload with BAR blockade, largely due to significant increases in SV. This suggests the AT subject's heart is capable of increasing SV to a large enough capacity to maintain flow when filling time is increased, despite pharmacological attenuation of the effects of adrenergic stimulation. Contrary to previous investigations (2, 14, 18, 42) , these results suggest that the Frank-Starling mechanism remains intact in AT during exercise intensities Ͼ40% V O 2max . Furthermore, these findings question the idea that the plateau in SV of the AT or sedentary subjects at 40 -45% V O 2max is a result of pericardial restraint (18, 42) . Indeed, previous data obtained from canines performing maximal treadmill exercise with and without an intact pericardium identified the presence of pericardial restraint only at near maximal exercise intensities (42) . It is apparent that, in ET subjects, the Frank-Starling mechanism is not as effective in increasing SV during exercise with BAR blockade, particularly at the moderate-intensity workload of 45% V O 2max . In addition, these findings indicate that the plateau in SV of the AT subjects at 40 -45% V O 2max is more likely to represent a balance between the cardiac filling time and the volume of venous return. Metoprolol competitively inhibits neurotransmitters from binding BARs, thereby reducing the effects of adrenergic stimulation, such as reducing phosphorylation of proteins by protein kinase A and indirectly attenuating increases in cardiomyocyte calcium entry and a reduction in the affinity of calcium to bind to the myofilaments (46) . This, in effect, reduces HR and contractility during exercise. However, the Frank-Starling mechanism alters the force of contraction via stretch of the cardiomyocytes' contractile filaments. Therefore, BAR blockade-induced longer filling times would allow for greater ventricular filling and increased stretch of the contractile filaments. A more forceful contraction would be reestablished as a result of the increase in stretch, despite the pharmacological reduction in contractility. The absence of an increase in SV in ET subjects at 45% V O 2max during BAR blockade indicates that the efficiency of the Frank-Starling mechanism was disrupted. This suggests that the ET subjects are not operating on the steeper portion of the Starling curve during cycling exercise with BAR blockade, as has been observed during various volume loads at rest (26) . Recently, it has been argued that increased stretch increases calcium sensitivity of the myofilaments, thereby increasing the force of contraction (16, 24, 25, 41) . Our results suggest BAR blockade-induced attenuation of calcium handling affects the myofilaments to a greater magnitude in ET compared with AT, specifically at moderate-intensity exercise.
We also demonstrated that the cardiac work performed at rest and during control exercise of the ET subjects was greater than that of the AT subjects. This suggests that endurance exercise training-induced increases in SV have a greater effect on cardiac work than the training-induced reductions in HR. However, BAR blockade reduced the cardiac work of the ET subjects during moderate-and heavy-intensity exercise, but only reduced the cardiac work of the AT subjects during the heavy-intensity exercise trial. The reductions in cardiac work of the ET subjects were a product of significant decreases in SBP, HR, and Q c. However, in the AT, the BAR blockade did not reduce the cardiac work during the 45% V O 2max exercise bout (Fig. 5) . Therefore, the SV was increased sufficiently to maintain cardiac work, despite there being significant reductions in SBP and HR. These findings further support the concept that the Frank-Starling mechanism of the AT subjects remained unimpaired by BAR blockade. It must be noted that the BAR blockade-induced attenuation of SV and Q c in ET subjects resulted in cardiac function similar to that of the AT subjects during exercise with metoprolol. Therefore, at the high-intensity workload, it is possible we are observing a pericardial restraint in the ET subjects. Pericardial restraint would prevent SV from increasing the required amount necessary to maintain the greater amount of cardiac work observed during control exercise in ET subjects compared with AT subjects.
In addition, we calculated myocardial efficiency as the myocardial work performed (i.e., the triple product) for a given whole body V O 2 (30) . Metoprolol, which reduces SBP (1, 4, 20, 28, 40, 45) , should effectively increase efficiency due to less pressure work and more volume work. However, we observed a decrease in myocardial efficiency with BAR blockade in every exercise trial compared with control, with the exception of the 45% V O 2max exercise of the AT subjects. This suggests that, during moderate exercise intensity with BAR blockade, the myocardium of the AT subjects relies less on increases in pressure and more on increases in volume to perform the same amount of work. Subsequently, the energy production necessary to perform a given amount of work was reduced and resulted in a more efficiently functioning heart (13) . A reduction in the amount of pressure generation necessary to produce the same amount of work would prove beneficial to patients with ischemic heart disease performing mildto-moderate exercise. Metoprolol is commonly prescribed to reduce the work of the heart during adrenergic stimulation associated with exercise, without changing cardiac efficiency. However, in the present investigation, the cardiac efficiency of the ET subjects was reduced. This reduction in cardiac efficiency of the ET subjects appeared related to their inability to increase SV at the low exercise intensities.
In the present investigation, a number of limitations need to be identified. A calculation of cardiac efficiency would ideally involve external cardiac work performed for a given mV O 2 . In addition, a direct measure of mV O 2 would have provided a more precise index of cardiac work (21) . However, these measurements are highly invasive and only measure global changes in mV O 2 without capability to isolate the LV V O 2 . Furthermore, the calculation of the triple product (HR ϫ SV ϫ SBP) has been established as a reliable index of cardiac work during changes in SV (r ϭ 0.926) (37) . In specific situations in which the ionotropic state of the myocardium was altered, the triple product calculation provided a more reliable index of cardiac work than the rate-pressure (HR ϫ SBP) product (37) . In addition, we did not challenge the efficacy of metoprolol using a selective agonist. However, according to the pharmacokinetic data of metoprolol, the peak activity of short-acting metoprolol is 2-4 h after oral administration (46) . Each of our experimental exercise sessions was conducted within this time window. In addition, the reductions observed in HR and SBP were comparable to the values reported in other studies using metoprolol and other cardio-selective BAR inhibitors (1, 4, 20, 28, 40, 45) .
We have demonstrated that, at moderate-intensity exercise with metoprolol, the AT subjects were able to maintain cardiac function, cardiac work, and cardiac efficiency. The effect of workload on cardiovascular function during BAR blockade may be a result of the effectiveness of the skeletal muscle pump. Previous studies have demonstrated that the compression of the veins in skeletal muscle during contraction is more effective in increasing venous return at mild-to-moderate exercise workloads (29, 38, 39) . The effect of the skeletal muscle pump juxtaposed with pharmacologically increased filling time may account for the maintenance in cardiovascular function in AT with moderate-intensity exercise that is dissipated at higher workloads. In contrast to our working hypothesis, BAR block-ade reduced the cardiac function, cardiac work, and cardiac efficiency of ET athletes during moderate-and heavy-intensity exercise. These results indicate that, with BAR blockade, the more efficient Frank-Starling mechanism is impaired in ET athletes but remains intact and functional in AT subjects during moderate intensities of exercise.
